Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Mehdi Bamorovat"'
Autor:
Mehdi Bamorovat, Iraj Sharifi, Ahmad Khosravi, Mohammad Reza Aflatoonian, Setareh Agha Kuchak Afshari, Ehsan Salarkia, Fatemeh Sharifi, Behnaz Aflatoonian, Faranak Gharachorloo, Ali Khamesipour, Mehdi Mohebali, Omid Zamani, Mohammad Reza Shirzadi, Mohammad Mahdi Gouya
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 1, Pp 22-34 (2024)
Abstract Leishmaniasis is a disease of poverty that imposes a devastating medical, social, and economic burden on over 1 billion people nationwide. To date, no in-depth study to analyze the major global challenges and needs assessment has been carrie
Externí odkaz:
https://doaj.org/article/a1d6a01e200648fe96d02a51ddc9d9d1
Autor:
Mehdi Bamorovat, Iraj Sharifi, Mehdi Shafiei Bafti, Setareh Agha Kuchak Afshari, Mohammad Reza Aflatoonian, Ali Karamoozian, Abdollah Jafarzadeh, Raheleh Amirzadeh, Ahmad Khosravi, Zahra Babaei, Farzane Safa, Fatemeh Sharifi, Amireh Heshmatkhah
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 1, Pp 142-153 (2024)
Abstract Introduction Emerging infectious diseases such as SARS-CoV-2 can cause pandemics and create a critical risk for humans. In a previous pilot study, we reported that the immunological responses induced by cutaneous leishmaniasis (CL) could dec
Externí odkaz:
https://doaj.org/article/0072c3ef180f474e9dafda66376fc0b5
Autor:
Fatemeh Seyedi, Iraj Sharifi, Ahmad Khosravi, Elaheh Molaakbari, Hadi Tavakkoli, Ehsan Salarkia, Sina Bahraminejad, Mehdi Bamorovat, Shahriar Dabiri, Zohreh Salari, Ali Kamali, Guogang Ren
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Various drugs have been used for the treatment of leishmaniasis, but they often have adverse effects on the body's organs. In this study, we aimed to explore the effects of one type of drug, Miltefosine (MIL), and its analogue or modifier, l
Externí odkaz:
https://doaj.org/article/02b0678902014a20b7c4d1394db9e84a
Autor:
Farzaneh Zarrinkar, Iraj Sharifi, Ehsan Salarkia, Alireza Keyhani, Zahra Babaei, Ali Khamesipour, Maryam Hakimi Parizi, Elaheh Molaakbari, Fatemeh Sharifi, Shahriar Dabiri, Mehdi Bamorovat
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0307537 (2024)
Currently, no safe vaccine against leishmaniasis is available. So far, different control strategies against numerous reservoir hosts and biological vectors have not been environment-friendly and feasible. Hence, employing medicinal components and con
Externí odkaz:
https://doaj.org/article/1e4a9ef3cdfb4d829e315ccfd9f0c122
Autor:
Mehdi Bamorovat, Iraj Sharifi, Setareh Agha Kuchak Afshari, Ali Karamoozian, Amirhossein Tahmouresi, Amireh Heshmatkhah, Ehsan Salarkia, Ahmad Khosravi, Maryam Hakimi Parizi, Maryam Barghi
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 21, Iss , Pp 21-27 (2023)
Leishmaniasis is an overlooked, poverty-stricken, and complex disease with growing social and public health problems. In general, leishmaniasis is a curable disease; however, there is an expansion of unresponsive cases to treatment in cutaneous leish
Externí odkaz:
https://doaj.org/article/b2c7b2c56a9a4a4d9fa0bee74647d3a4
Autor:
Mehdi Bamorovat, Iraj Sharifi, Mohammad Reza Aflatoonian, Ali Karamoozian, Amirhossein Tahmouresi, Abdollah Jafarzadeh, Amireh Heshmatkhah, Fatemeh Sharifi, Ehsan Salarkia, Tabandeh Khaleghi, Ahmad Khosravi, Maryam Nooshadokht, Mehdi Borhani Zarandi, Maryam Barghi
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 155-161 (2022)
ABSTRACT: Introduction: We assessed the potential relationship between COVID-19 and laboratory-confirmed cutaneous leishmaniasis (CL)-registered cases with a history of scarring, compared with volunteer participants without history of CL. Methods: Th
Externí odkaz:
https://doaj.org/article/dd8fbf743b3941a2bc510672d8a58097
Autor:
Iraj Sharifi, Ahmad Khosravi, Mohammad Reza Aflatoonian, Ehsan Salarkia, Mehdi Bamorovat, Ali Karamoozian, Mahmoud Nekoei Moghadam, Fatemeh Sharifi, Abbas Aghaei Afshar, Setareh Agha Kuchak Afshari, Faranak Gharachorloo, Mohammad Reza Shirzadi, Behzad Amiri, Mohammad Zainali, Sara Doosti, Omid Zamani, Mohammad Mahdi Gouya
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Iran has invariably been under the growing public health threat of cutaneous leishmaniasis (CL), a significant barrier to local development that hinders the prevention and control efforts toward eliminating the disease. So far, no comprehensive and i
Externí odkaz:
https://doaj.org/article/91876d4c8fb34c8ab9d4197c655ccf6c
Autor:
Ali Derakhshani, Iraj Sharifi, Ehsan Salarkia, Alireza Keyhani, Setareh Agha Kuchak Afshari, Behzad Iranmanesh, Mahdieh Lashkarizadeh, Hamid Nejad Biglari, Moslem Lari Najafi, Mehdi Bamorovat
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0291321 (2023)
This study aimed to investigate the in vitro and in silico antileishmanial activity of azacitidine (AZA) on Leishmania major promastigotes and amastigotes. The in silico method was used to evaluate the possibility of the interaction of AZA into the b
Externí odkaz:
https://doaj.org/article/7605db707c9749f5a4d1c36d7c223b11
Autor:
Ehsan Salarkia, Iraj Sharifi, Alireza Keyhani, Razieh Tavakoli Oliaee, Ahmad Khosravi, Fatemeh Sharifi, Mehdi Bamorovat, Zahra Babaei
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0291322 (2023)
A significant barrier to optimal antileishmanial treatment is low efficacy and the emergence of drug resistance. Multiple approaches were used to monitor and assess crocin (a central component of saffron) mixed with amphotericin B (AmpB) potential in
Externí odkaz:
https://doaj.org/article/d6d30057462b49d6896bf5401d5d3c9e
Autor:
Ahmad Khosravi, Iraj Sharifi, Hadi Tavakkoli, Elaheh Molaakbari, Sina Bahraminegad, Ehsan Salarkia, Fatemeh Seyedi, Alireza Keyhani, Zohreh Salari, Fatemeh Sharifi, Mehdi Bamorovat, Ali Afgar, Shahriar Dabiri
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Leishmaniasis has been identified as a significant disease in tropical and subtropical regions of the world, with Iran being one of the disease-endemic areas. Various treatments have been applied for this disease, and amphotericin B (Amp B) is the se
Externí odkaz:
https://doaj.org/article/ba14d43ffb774b57acb06911aa761eb6